Two Sigma Advisers
ABMD

Two Sigma Advisers’s Abiomed Inc ABMD Stock Holding History

Two Sigma Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-111,499
Closed -$27.4M – 2770
2022
Q3 		$27.4M Sell
111,499
-23,200
-17% -$6.26M 0.08% 252
2022
Q2 		$33.3M Buy
134,699
+21,500
+19% +$5.8M 0.09% 228
2022
Q1 		$37.5M Sell
113,199
-27,300
-19% -$8.4M 0.1% 205
2021
Q4 		$50.5M Buy
140,499
+21,600
+18% +$7.3M 0.13% 158
2021
Q3 		$38.7M Buy
118,899
+13,400
+13% +$4.54M 0.1% 201
2021
Q2 		$32.9M Buy
105,499
+72,600
+221% +$22.3M 0.09% 229
2021
Q1 		$10.5M Buy
32,899
+28,699
+683% +$9.18M 0.03% 554
2020
Q4 		$1.36M Sell
4,200
-5,399
-56% -$1.49M ﹤0.01% 1431
2020
Q3 		$2.66M Sell
9,599
-7,601
-44% -$2.19M 0.01% 1022
2020
Q2 		$4.16M Buy
17,200
+6,269
+57% +$1.26M 0.01% 876
2020
Q1 		$1.59M Sell
10,931
-76,599
-88% -$12.7M 0.01% 1233
2019
Q4 		$14.9M Sell
87,530
-20,600
-19% -$3.82M 0.03% 465
2019
Q3 		$19.2M Sell
108,130
-227,100
-68% -$49.1M 0.05% 384
2019
Q2 		$87.3M Buy
335,230
+183,400
+121% +$48.7M 0.22% 123
2019
Q1 		$43.4M Sell
151,830
-19,300
-11% -$6.41M 0.11% 234
2018
Q4 		$55.6M Sell
171,130
-229,301
-57% -$79.7M 0.15% 179
2018
Q3 		$180M Sell
400,431
-211,100
-35% -$83.2M 0.44% 56
2018
Q2 		$250M Buy
611,531
+579,601
+1,815% +$210M 0.67% 19
2018
Q1 		$9.29M Buy
31,930
+20,500
+179% +$5.2M 0.03% 611
2017
Q4 		$2.14M Buy
11,430
+800
+8% +$149K 0.01% 1211
2017
Q3 		$1.79M Buy
10,630
+1,900
+22% +$287K 0.01% 1271
2017
Q2 		$1.25M Buy
+8,730
New +$1.17M ﹤0.01% 1417
2017
Q1 		– Sell
-2,430
Closed -$274K – 2505
2016
Q4 		$274K Sell
2,430
-71,100
-97% -$8.24M ﹤0.01% 2101
2016
Q3 		$9.45M Buy
73,530
+70,800
+2,593% +$8.48M 0.04% 439
2016
Q2 		$298K Sell
2,730
-2,600
-49% -$259K ﹤0.01% 1718
2016
Q1 		$505K Buy
+5,330
New +$450K ﹤0.01% 1452
2015
Q4 		– Sell
-149,930
Closed -$14M – 2064
2015
Q3 		$14M Buy
149,930
+73,600
+96% +$6.48M 0.09% 268
2015
Q2 		$5.02M Buy
76,330
+41,500
+119% +$2.76M 0.04% 478
2015
Q1 		$2.49M Sell
34,830
-7,500
-18% -$407K 0.02% 694
2014
Q4 		$1.61M Buy
+42,330
New +$1.34M 0.01% 924
2013
Q3 		– Sell
-18,730
Closed -$404K – 2479
2013
Q2 		$404K Buy
+18,730
New +$376K 0.01% 1485

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Advisers's ABMD Position: Q4 2022 in Review

Two Sigma Advisers sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 111,499 shares — an estimated $27.4M sold.

Two Sigma Advisers first reported a position in ABMD in Q2 2013 and held it in 31 quarters. The position peaked at $250M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Two Sigma Advisers reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 111,499 Abiomed Inc shares in Q4 2022, an estimated $27.4M.
  • Two Sigma Advisers first reported a position in Abiomed Inc in Q2 2013 and held it in 31 quarters.
  • Two Sigma Advisers's Abiomed Inc position peaked at $250M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.